Gene · 780
Papers2,465
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 2,465
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Research progress on the role of DDR1 in cancer and targeted therapy strategy. | Neoplasma | 2026 | 41709753 | PubTator, text mining | PubMed |
| Insights into the proteome of next-generation probiotic Faecalibacterium duncaniae A2-165 through label-free proteomics approach. | BMC Microbiol | 2026 | 41709136 | PubTator, text mining | PubMed |
| Coordinated DNA methyltransferase 3A and methyltransferase-like 7A activity reprograms the tumor microenvironment through discoidin domain receptor 1 signaling. | Cancer Biol Med | 2026 | 41700824 | PubTator, text mining | PubMed |
| Y chromosome-linked EIF1AY deletion drives sex differences in multiple myeloma. | NPJ Precis Oncol | 2026 | 41688674 | PubTator, text mining | PubMed |
| Cellular Context Influences Kinase Inhibitor Selectivity. | J Med Chem | 2026 | 41651452 | PubTator, text mining | PubMed |
| RAF1 as a standalone therapeutic target in KRAS-driven lung adenocarcinoma: No added efficacy from co-targeting ARAF, EGFR, or DDR1. | PLoS One | 2026 | 41650121 | PubTator, text mining | PubMed |
| Enhancing Drug Repurposing with Consensus Docking: Discovery of Novel Discoidin Domain Receptor 1 Inhibitors. | ChemMedChem | 2026 | 41619308 | PubTator, text mining | PubMed |
| Surface markers on supermeres outperform extracellular vesicles in colorectal cancer diagnosis. | Sci Rep | 2026 | 41571721 | PubTator, text mining | PubMed |
| Selective targeting of NRF2-high pancreatic ductal adenocarcinoma with an NQO1-activatable prodrug. | Proc Natl Acad Sci U S A | 2026 | 41564125 | PubTator, text mining | PubMed |
| Mechanisms of DDR1 in Reinforcing the Resistance to Radiotherapy in Breast Cancer Through the AMPK/SIRT1/PGC-1α Pathway. | Biochem Genet | 2026 | 41557071 | PubTator, text mining | PubMed |
| Global Evaluation of Congenital Heart Disease-Associated Non-Coding Variants. | Res Sq | 2026 | 41542063 | PubTator, text mining | PubMed |
| Mixed-model and transcriptome-wide association analyses identify transcription factors and genes associated with colorectal cancer susceptibility. | Nat Commun | 2026 | 41540004 | PubTator, text mining | PubMed |
| Bioorthogonal Sonodynamic Plug-and-Play Targeting Chimeras (SDPTAC) for Precise Targeted Protein Degradation. | Adv Sci (Weinh) | 2026 | 41431111 | PubTator, text mining | PubMed |
| DDR1 Regulates Femoral Arterial Calcification in Lower-Extremity Artery Disease Through NF-Kappa B Activation. | Acta Physiol (Oxf) | 2026 | 41399911 | PubTator, text mining | PubMed |
| Immunological conversion of triple-negative breast cancer by engineered extracellular vesicle-mediated pyroptosis. | J Control Release | 2026 | 41344487 | PubTator, text mining | PubMed |
| Discoidin Domain Receptor 1 in Colonic Epithelial Cells: A Paracrine Driver of Colonic Fibrosis. | Curr Pharm Biotechnol | 2026 | 41088926 | PubTator, text mining | PubMed |
| Susceptibility and protective genes in diabetic retinopathy: A comprehensive single-cell RNA sequencing analysis. | Exp Eye Res | 2026 | 41076048 | PubTator, text mining | PubMed |
| The Diagnostic Role and Potential Pharmacological Value of DDR1 in Pan-Cancer. | Curr Top Med Chem | 2026 | 40676791 | PubTator, text mining | PubMed |
| Recent Progression and Treatment Approaches of Kidney Fibrosis: Evidence to Clinic Approach. | Endocr Metab Immune Disord Drug Targets | 2026 | 40551698 | PubTator, text mining | PubMed |
| Smart polymeric nanoparticles for targeted delivery and microenvironment-responsive therapy in pancreatic cancer. | Smart Mater Med | 2025 | 41869550 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/780/papers?page=4